Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 204
Selected: 0
NCT IDTitle
NCT04629846Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.
NCT05060419Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections
NCT05829616A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors
NCT07138833A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)
NCT04632758Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
NCT05703204A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT06749899QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.
NCT06742138To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma
NCT06613880Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
NCT07152444A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension
NCT05823246Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma
NCT05922436a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency
NCT04326829QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors
NCT05052567CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma
NCT07198633A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
NCT06686576A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer
NCT06394713A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors
NCT07062978A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
NCT05803642A Study of Olanzapine in Patients With Acute Agitation
NCT06151587A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children
NCT06614907A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent®
NCT06980909The Food Effect on Pharmacokinetics Study of QLC1101 in Healthy Subjects
NCT06760676A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy
NCT05920876A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma
NCT06058000A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
NCT04157699An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b
NCT07040228A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer
NCT03651947Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults
NCT05629949A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer
NCT07127822Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
NCT05860530Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers
NCT05528198Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fasted Healthy Volunteers
NCT05973149Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer
NCT07151872Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer
NCT06047431A Study of QL1706H in Patients With Advanced Solid Tumors
NCT06649214A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia
NCT05557565A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer
NCT07040826Lifitegrast Eye Drops in Healthy Subjects:Phase I Study
NCT03557580A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects
NCT06954246A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT04234594Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.
NCT06898060To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture
NCT07256782A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
NCT06007586Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients
NCT07331545Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults
NCT04213105Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults
NCT05150405A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors
NCT05531994Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fed Healthy Volunteers
NCT07327697A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects
NCT05801107Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients